Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v41-EN Version v40-EN
Language English English
Date Updated 2024-02-14 2023-10-06
Drug Identification Number 00628158 00628158
Brand name APO-AMOXI APO-AMOXI
Common or Proper name AMOXICILLAN AMOXICILLAN
Company Name APOTEX INC APOTEX INC
Ingredients AMOXICILLIN AMOXICILLIN
Strength(s) 250MG 250MG
Dosage form(s) POWDER FOR SUSPENSION POWDER FOR SUSPENSION
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100mL and 150mL 100mL and 150mL
ATC code J01CA J01CA
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2022-06-15 2022-06-15
Estimated end date 2023-10-13 2023-10-13
Actual end date 2023-10-05 2023-10-05
Shortage status Resolved Resolved
Tier 3 Status No Yes
Company comments
Health Canada comments